The Secreted Aminopeptidase of Pseudomonas aeruginosa (PaAP)
1Maurice and Gabriela Goldschleger Eye Research Institute, Faculty of Medicine and Health Sciences, Sheba Medical Center, Tel Aviv University, Ramat-Gan 5262000, Israel.
Abstract:
Pseudomonas aeruginosa is an opportunistic pathogen that causes severe infections in compromised hosts. P. aeruginosa infections are difficult to treat because of the inherent ability of the bacteria to develop antibiotic resistance, secrete a variety of virulence factors, and form biofilms. The secreted aminopeptidase (PaAP) is an emerging virulence factor, key in providing essential low molecular weight nutrients and a cardinal modulator of biofilm development. PaAP is therefore a new potential target for therapy of P. aeruginosa infections. The present review summarizes the current knowledge of PaAP, with special emphasis on its biochemical and enzymatic properties, activation mechanism, biological roles, regulation, and structure. Recently developed specific inhibitors and their potential as adjuncts in the treatment of P. aeruginosa infections are also described.
Insights
Pseudomonas aeruginosa infections are hard to treat due to antibiotic resistance and biofilm formation. The secreted aminopeptidase (PaAP) is a key virulence factor and potential therapeutic target for these difficult-to-treat bacterial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Biochemistry
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen causing severe infections in vulnerable individuals.
- Treatment challenges include antibiotic resistance, virulence factors, and biofilm formation.
- Secreted aminopeptidase (PaAP) is an emerging virulence factor influencing nutrient acquisition and biofilm development.
Purpose of the Study:
- To review current knowledge on Pseudomonas aeruginosa secreted aminopeptidase (PaAP).
- To highlight PaAP's biochemical properties, biological roles, and regulation.
- To discuss PaAP inhibitors as potential therapeutic adjuncts.
Main Methods:
- Literature review of studies on PaAP.
- Analysis of biochemical and enzymatic properties.
- Examination of structural and regulatory mechanisms.
Main Results:
- PaAP is crucial for nutrient provision and biofilm modulation.
- Understanding PaAP's activation mechanism is key.
- Specific PaAP inhibitors show promise as adjunct therapies.
Conclusions:
- PaAP is a significant virulence factor and a promising therapeutic target for P. aeruginosa infections.
- Inhibitors of PaAP could enhance current treatment strategies.
- Further research into PaAP is warranted for novel anti-pseudomonal therapies.
Related Concept Videos
01:23Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:02Protein Digestion
01:13The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
01:26Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...